Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
J Neuropsychiatry Clin Neurosci. 2009 Fall;21(4):371-80. doi: 10.1176/appi.neuropsych.21.4.371.

Catatonia: clinical aspects and neurobiological correlates.

Author information

  • NY-Presbyterian Hospital/Weill Cornell Medical Center, Department of Psychiatry, 525 East 68th St., Box 140, New York, NY 10065, USA. jed7002@med.cornell.edu

Abstract

Catatonia is a neuropsychiatric syndrome that can occur due to medical or psychiatric disorder. This review synthesizes over 20 years of original research and comprehensive review articles with attention to the most recent findings. Though catatonia is common and highly treatable, there have been few research studies investigating the syndrome. Pooled case reports suggest that catatonia due to an underlying general medical condition and catatonia due to a psychiatric illness can be treated similarly and that the catatonic symptoms and the underlying illness must be addressed in both types. Benzodiazepines and ECT continue to be mainstays of treatment. Evidence is mounting for the use of NMDA antagonists in catatonia refractory to lorazepam.

PMID:
19996245
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk